Puma Biotechnology Inc (PBYI)
2.90
+0.06
(+2.11%)
USD |
NASDAQ |
Nov 21, 16:00
2.905
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Max Drawdown (5Y): 98.76% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.76% |
| September 30, 2024 | 98.76% |
| August 31, 2024 | 98.76% |
| July 31, 2024 | 98.76% |
| June 30, 2024 | 98.76% |
| May 31, 2024 | 98.76% |
| April 30, 2024 | 98.76% |
| March 31, 2024 | 98.76% |
| February 29, 2024 | 98.76% |
| January 31, 2024 | 98.76% |
| December 31, 2023 | 98.76% |
| November 30, 2023 | 98.76% |
| October 31, 2023 | 98.76% |
| September 30, 2023 | 98.76% |
| August 31, 2023 | 98.76% |
| July 31, 2023 | 98.76% |
| June 30, 2023 | 98.76% |
| May 31, 2023 | 98.76% |
| April 30, 2023 | 98.76% |
| March 31, 2023 | 98.76% |
| February 28, 2023 | 98.76% |
| January 31, 2023 | 98.76% |
| December 31, 2022 | 98.76% |
| November 30, 2022 | 98.76% |
| October 31, 2022 | 98.76% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.76% |
| August 31, 2022 | 98.76% |
| July 31, 2022 | 98.76% |
| June 30, 2022 | 98.76% |
| May 31, 2022 | 98.76% |
| April 30, 2022 | 98.39% |
| March 31, 2022 | 98.39% |
| February 28, 2022 | 98.39% |
| January 31, 2022 | 98.30% |
| December 31, 2021 | 97.85% |
| November 30, 2021 | 97.67% |
| October 31, 2021 | 97.46% |
| September 30, 2021 | 97.46% |
| August 31, 2021 | 97.46% |
| July 31, 2021 | 97.46% |
| June 30, 2021 | 97.46% |
| May 31, 2021 | 97.46% |
| April 30, 2021 | 97.46% |
| March 31, 2021 | 97.46% |
| February 28, 2021 | 97.46% |
| January 31, 2021 | 97.46% |
| December 31, 2020 | 97.46% |
| November 30, 2020 | 97.46% |
| October 31, 2020 | 97.46% |
| September 30, 2020 | 97.46% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.43%
Minimum
Nov 2019
98.76%
Maximum
May 2022
98.18%
Average
98.58%
Median
Max Drawdown (5Y) Benchmarks
| Pfizer Inc | 54.78% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -32.42 |
| Beta (5Y) | 1.092 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 84.41% |
| Historical Sharpe Ratio (5Y) | -0.2171 |
| Historical Sortino (5Y) | -0.4444 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.73% |